InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the full record of transactions filed by Chaubey Alka. Director active across 1 company, notably Bionano Genomics, Inc.. Aggregated, 7 disclosures have been recorded. History available since 15 February 2023. The latest transaction was disclosed on 3 June 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
7 of 7 declarations